Bevacizumab Treatment for Meningiomas in NF2: A Retrospective Analysis of 15 Patients

Bevacizumab treatment can result in tumor shrinkage of progressive vestibular schwannomas in some neurofibromatosis 2 (NF2) patients but its effect on meningiomas has not been defined. To determine the clinical activity of bevacizumab against NF2-related meningiomas, we measured changes in volume of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Fabio P., Merker, Vanessa L., Jennings, Dominique, Caruso, Paul A., di Tomaso, Emmanuelle, Muzikansky, Alona, Barker, Fred G., Stemmer-Rachamimov, Anat, Plotkin, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605344/
https://www.ncbi.nlm.nih.gov/pubmed/23555840
http://dx.doi.org/10.1371/journal.pone.0059941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605344/
https://www.ncbi.nlm.nih.gov/pubmed/23555840
http://dx.doi.org/10.1371/journal.pone.0059941

Ejemplares similares